• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Death (1802); Right Ventricular Dysfunction (2054); Hemorrhagic Stroke (4417); Heart Failure/Congestive Heart Failure (4446)
Event Date 11/12/2020
Event Type  Death  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
Related manufacturer report number: 2916596-2020-06045.It was reported that the patient showed signs of worsening right ventricular (rv) dysfunction following pump exchange on (b)(6) 2020.The patient's hemodynamics showed increasing central venous pressure (cvp) and worsening rv dilatation.The decision was made to place centrimag rvad and the patient was centrally cannulated and their chest was closed.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a specific cause for the reported right ventricle dysfunction, hemorrhagic stroke, and subsequent patient outcome, as well as a direct correlation to heartmate 3 left ventricular assist system (lvas), serial number (b)(4), could not be conclusively determined through this evaluation.The relevant sections of the device history records for (b)(4) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on 14oct2020.The current heartmate 3 left ventricular assist system (lvas) instructions for use (ifu) lists right heart failure, stroke, and death as adverse events that may be associated with the use of the heartmate 3 left ventricular assist system in section 1, ¿introduction¿.Neurological dysfunction is also listed as a potential late postimplant complication in section 6 ¿patient care and management¿.Section 6 entitled ¿patient care and management¿ cautions the user that right heart failure can occur following implantation of the pump and warns that ¿right heart dysfunction, especially when combined with elevated pulmonary vascular resistance, may limit the effectiveness of the left ventricular assist system due to reduced filling of the pump¿.This section also outlines the associated treatment options, including rvad placement.Section 6 (under "anticoagulation") also outlines the recommended anticoagulation regimen (including inr range) for patients using the heartmate 3 lvas as well as the suggested anticoagulation modifications in the event there is a risk of bleeding.No further information was provided.The manufacturer is closing the file on this event.
 
Event Description
It was additionally reported that the patient suffered a large hemorrhagic stroke.A computed tomography (ct) scan was done to diagnose the stroke.The patient passed away due to stroke and withdrawal of care on (b)(6) 2020.
 
Manufacturer Narrative
Section b2: additional information; section b5: additional information; section d6: correction; section h1: report type has been corrected: updated from serious injury to death report; section h6: additional information - patient codes; no further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key10960457
MDR Text Key219984940
Report Number2916596-2020-05981
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 01/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/07/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/17/2022
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number7670573
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/20/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
HEARTMATE 3 LVAS IMPLANT KIT(SN: (B)(4).; HEARTMATE 3 LVAS IMPLANT KIT(SN: (B)(4))
Patient Outcome(s) Death; Hospitalization; Required Intervention;
Patient Age59 YR
Patient Weight54
-
-